Details of the Drug

General Information of Drug (ID: DM26RE4)

Drug Name

GX-G3

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01951027) Phase I Study GX-G3 in Healthy Subjects. U.S. National Institutes of Health.